In re Lamictal Indirect Purchaser & Antitrust Consumer Litigation

*731OPINION

Walls, Senior District Judge

This putative class action concerns the legality of a settlement between two pharmaceutical. companies. Plaintiffs are indirect purchasers of the drug lamotrigine, known by its brand name Lamictal, whieh was the subject of patent litigation between the Defendant pharmaceutical companies. Plaintiffs allege that the terms of the litigation settlement and the resulting sales of branded and generic versions of Lamictal violated federal and state antitrust and consumer protection laws. Defendants move ■ to dismiss on - various grounds, including that Plaintiffs’…